Emerging Phytochemicals for the Prevention and Treatment of Head and Neck Cancer
Despite the development of more advanced medical therapies, cancer management remains a problem. Head and neck squamous cell carcinoma (HNSCC) is a particularly challenging malignancy and requires more effective treatment strategies and a reduction in the debilitating morbidities associated with the...
Main Author: | Santosh K. Katiyar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/21/12/1610 |
Similar Items
-
Retrospective analysis to assess the feasibility of escalated dose of nimotuzumab in patients with locally advanced head and neck cancer
by: Nagraj Gururaj Huilgol, et al.
Published: (2017-01-01) -
Recent advances of novel targeted therapy for squamous cell carcinoma of the head and neck
by: Jed A. Katzel, et al.
Published: (2011-12-01) -
Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitors
by: Sacco AG, et al.
Published: (2016-04-01) -
Clinical Observation of Nimotuzumab Combined with Docetaxel and Cisplatin in First-line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
by: ZHU Qiuxia, et al.
Published: (2021-06-01) -
Association of Epidermal Growth Factor Receptor (EGFR) with Tumor Location and Clinicopathological Aspect in Head and Neck Squamous Cell Carcinoma
by: I Nyoman Diwiya Abdi Nuratna, et al.
Published: (2016-06-01)